FdaApplication
NDA 214860
Identifiers
- fda_app_no: NDA214860
Properties
| Property | Value |
|---|---|
| applicant_name | ACER THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2022-12-22 |
Products (8)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OLPRUVA | SODIUM PHENYLBUTYRATE | 6.67GM/PACKET | FOR SUSPENSION;ORAL |
| OLPRUVA | SODIUM PHENYLBUTYRATE | 3GM/PACKET | FOR SUSPENSION;ORAL |
| OLPRUVA | SODIUM PHENYLBUTYRATE | 1GM/PACKET | FOR SUSPENSION;ORAL |
| OLPRUVA | SODIUM PHENYLBUTYRATE | 6GM/PACKET | FOR SUSPENSION;ORAL |
| OLPRUVA | SODIUM PHENYLBUTYRATE | 0.5GM/PACKET | FOR SUSPENSION;ORAL |
| OLPRUVA | SODIUM PHENYLBUTYRATE | 2GM/PACKET | FOR SUSPENSION;ORAL |
| OLPRUVA | SODIUM PHENYLBUTYRATE | 4GM/PACKET | FOR SUSPENSION;ORAL |
| OLPRUVA | SODIUM PHENYLBUTYRATE | 5GM/PACKET | FOR SUSPENSION;ORAL |
8 products